Neutralizing antibodies against SARS-CoV-2 in Brazilian pregnant women vaccinated with one or two doses of BNT162b2 mRNA vaccine (Pfizer/WyethTM)

Neutralizing antibodies against SARS-CoV-2 in Brazilian pregnant women vaccinated with one or two doses of BNT162b2 mRNA vaccine (Pfizer/WyethTM)

Pregnant women have an increased risk of developing severe coronavirus disease. In Brazil, the number of hospitalizations and adverse outcomes, including death caused by COVID-19, in women during the pregnancy-puerperal cycle was high in the first pandemic year. Doubts regarding vaccines' effic...

Full description

Bibliographic Details
Main Authors: Mauro César da Silva, Neila Caroline Henrique da Silva, Ana Laura Carneiro Gomes Ferreira, Fernanda Carneiro Gomes Ferreira, Maria Inês Bezerra de Melo, Letícia Micherlyne Xavier da Silva, Camila Rodrigues de Melo Barbosa, Jurandy Júnior Ferraz de Magalhães, George Tadeu Nunes Diniz, Ariani Impieri Souza, Norma Lucena-Silva
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Public Health
Subjects:
COVID-19
pregnancy
vaccines
neutralizing antibodies
IgG
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.1054460/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.1054460/full

Similar Items